EP1302204A1 - Vanilloid Rezeptor Antagonisten zur Behandlung von Atemwegsverengungen - Google Patents

Vanilloid Rezeptor Antagonisten zur Behandlung von Atemwegsverengungen

Info

Publication number
EP1302204A1
EP1302204A1 EP01610108.1A EP01610108A EP1302204A1 EP 1302204 A1 EP1302204 A1 EP 1302204A1 EP 01610108 A EP01610108 A EP 01610108A EP 1302204 A1 EP1302204 A1 EP 1302204A1
Authority
EP
European Patent Office
Prior art keywords
airways
treatment
receptor antagonists
vanilloid receptor
constriction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01610108.1A
Other languages
English (en)
French (fr)
Inventor
Staffan Skogvall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Respiratorius AB
Original Assignee
Respiratorius AB
Filing date
Publication date
Application filed by Respiratorius AB filed Critical Respiratorius AB
Publication of EP1302204A1 publication Critical patent/EP1302204A1/de
Withdrawn legal-status Critical Current

Links

EP01610108.1A 2001-10-15 Vanilloid Rezeptor Antagonisten zur Behandlung von Atemwegsverengungen Withdrawn EP1302204A1 (de)

Publications (1)

Publication Number Publication Date
EP1302204A1 true EP1302204A1 (de) 2003-04-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP1425277B8 (de) Harnstoff-derivate als vanilloid-rezeptor-antagonisten für die schmerzbehandlung
IL209842A0 (en) Compounds for the treatment of metabolic disorders
ZA200305691B (en) The use of substituted azetidione compounds for the treatment of sitosterolemia
AU2002339691A1 (en) Agonists and antagonists of prolixin for the treatment of metabolic disorders
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
AU2002356525A1 (en) Substituted amines for the treatment of neurological disorders
IL162485A0 (en) Compounds for the treatment of inflammatory disorders
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
PL373835A1 (en) Use of cd23 antagonists for the treatment of neoplastic disorders
AU2002308315A1 (en) Diagnosis of physiological conditions by proteomic characterization
EP1461030A4 (de) Aminoalkyl-benzofuran-5-ol-verbindungen zur behandlung von glaukom
AU2002358469A1 (en) Modified receptors for the discovery of therapeutic ligands
AU2003264297A1 (en) Use of vanilloid receptor antagonists for the treatment of pain
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
AU2003273856A1 (en) Vr1 antagonists for the treatment of urological disorders
EP1302204A1 (de) Vanilloid Rezeptor Antagonisten zur Behandlung von Atemwegsverengungen
AU2003259759A1 (en) Gal3 receptor antagonists for the treatment of affective disorders
AU2002315522A1 (en) Receptor agonists useful for the treatment of pain
AU2002366272A1 (en) Edg-receptor agonist for the treatment of hypertension